Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells.
about
How to Define the Latent Reservoir: Tools of the TradeThe immunological synapse: the gateway to the HIV reservoirImpact of antiretroviral therapy (ART) timing on chronic immune activation/inflammation and end-organ damageThe end of AIDS: HIV infection as a chronic diseaseImmuno-virological discordance and the risk of non-AIDS and AIDS events in a large observational cohort of HIV-patients in EuropeActivation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapyDeterminants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccineReduction of HIV persistence following transplantation in HIV-infected kidney transplant recipientsSystemic effects of inflammation on health during chronic HIV infectionLevels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation.HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality.Immune activation and HIV persistence: considerations for novel therapeutic interventions.Frequency and impact of suboptimal immune recovery on first-line antiretroviral therapy within the International Epidemiologic Databases to Evaluate AIDS in East Africa.Immunologic strategies for HIV-1 remission and eradication.Low proportions of CD28- CD8+ T cells expressing CD57 can be reversed by early ART initiation and predict mortality in treated HIV infection.Comparison of HIV DNA and RNA in gut-associated lymphoid tissue of HIV-infected controllers and noncontrollers.Limited HIV infection of central memory and stem cell memory CD4+ T cells is associated with lack of progression in viremic individuals.Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection.Chronic HIV disease and activation of the coagulation systemImmune activation and HIV persistence: implications for curative approaches to HIV infection.Programmed death-1 expression on CD4⁺ and CD8⁺ T cells in treated and untreated HIV disease.CD4+ and CD8+ T cell activation are associated with HIV DNA in resting CD4+ T cellsImmune activation in HIV-infected aging women on antiretrovirals--implications for age-associated comorbidities: a cross-sectional pilot study.Exploring the potential of monoclonal antibody therapeutics for HIV-1 eradication.Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers.Impact of HIV on CD8+ T cell CD57 expression is distinct from that of CMV and aging.Select host restriction factors are associated with HIV persistence during antiretroviral therapy.HIV Type 1 Disease Progression to AIDS and Death in a Rural Ugandan Cohort Is Primarily Dependent on Viral Load Despite Variable Subtype and T-Cell Immune Activation LevelsInterleukin-37 Expression Is Increased in Chronic HIV-1-Infected Individuals and Is Associated with Inflammation and the Size of the Total Viral ReservoirLeveraging Cancer Therapeutics for the HIV Cure Agenda: Current Status and Future DirectionsCD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART.During Stably Suppressive Antiretroviral Therapy Integrated HIV-1 DNA Load in Peripheral Blood is Associated with the Frequency of CD8 Cells Expressing HLA-DR/DP/DQ'Emergency exit' of bone-marrow-resident CD34(+)DNAM-1(bright)CXCR4(+)-committed lymphoid precursors during chronic infection and inflammationVirologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery.Impact of a decade of successful antiretroviral therapy initiated at HIV-1 seroconversion on blood and rectal reservoirs.Interleukin-21 combined with ART reduces inflammation and viral reservoir in SIV-infected macaquesIncreasing procaspase 8 expression using repurposed drugs to induce HIV infected cell death in ex vivo patient cells.Naturally Occurring Subclinical Endotoxemia in Humans Alters Adaptive and Innate Immune Functions through Reduced MAPK and Increased STAT1 PhosphorylationContinued Slow Decay of the Residual Plasma Viremia Level in HIV-1-Infected Adults Receiving Long-term Antiretroviral Therapy.HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients.
P2860
Q26766705-9E6A0E63-0339-4C93-B296-C3B6C6525ED4Q27002959-74653FCB-0514-4BA8-96C9-6BB80A4E3BFDQ27014077-20488CF8-2E22-408A-A4D1-81C757C2793CQ28300749-85B92EE9-D5DC-4F0D-B7FC-F96750289F47Q28539369-1DB0C35C-0622-43F8-ADE2-A15312DB3A9EQ28544949-D1868127-7DF4-4F73-AF1C-95ECECE4DA70Q30373691-20105E9F-C125-473A-89A8-D126CBEE9AB1Q33575261-A22EC785-6DFC-47A2-BE2F-AD1DDF4431C7Q33577551-DAB45630-A5CA-4203-A7BB-8A8E684AB6B1Q33585386-D8182978-F037-4AE3-9C0B-D8FA8AD7DC12Q33618542-7EF9189F-C555-47BB-AD3B-3164B4E17A30Q33698781-8FEBE6EC-E327-4E89-9D98-07E17A29BBD3Q33707759-6DC242EF-BC38-4818-9609-FB92C44A918DQ33896523-EE428EB1-6949-4864-848F-DE666FA23064Q33947817-A9508214-E99E-4FF8-BBA7-AAD87D7950BDQ34083315-7F6B57EA-4CAB-4808-9580-2DD1B250682CQ34105477-88B41669-386B-4EAE-903E-065A7D12BEFDQ34315572-684649CE-2F19-47BF-99EA-EFE281961684Q34342368-823958DF-EBDE-4AB7-9F14-CECB9D348057Q34351320-F8A530AF-4FA3-41F2-A31B-09E5C0CFFF79Q34388154-E7BC8E31-A2D4-4EDA-92E8-8CA9B236229CQ34395160-7DFA95CB-2B0E-49A6-8795-0287770DBB88Q34749335-810C5E7B-1AD2-4DAF-97E1-4D04579F52E1Q34869927-B66024C4-7D81-487B-A3B1-4972E9ACE967Q35018065-5C2E754B-3AAB-48B0-97A5-0431B35483BCQ35107330-A0C23DC5-63BD-4E24-85E9-9937B19A3C22Q35271996-F2A43FFC-9904-4DD6-BACA-7A33EFF28FECQ35588137-E27F00A4-5AED-4855-ADB1-582C39983050Q35946786-90E91F6B-2462-4493-AECC-F9D6A8FC582CQ36030989-66F71CA0-8432-4BA4-B6E4-B34D7F9ADB75Q36077348-09D3C1BF-377C-4851-BE66-958FE4B559A7Q36106294-432C0901-1410-47D6-8DC5-29E71D2752EAQ36145878-D9F0BA5B-B26D-4196-B5E2-A48C0D751915Q36263361-B7A6DA75-4708-484D-98B7-1106FFB7C688Q36311695-26DFED9B-3113-4CCD-8733-91E06712EEB4Q36335882-CE323D4B-D78C-44C7-AE3C-478EF062455EQ36409179-8D5B9FC7-D19A-420E-A3E8-287616D1088EQ36447529-254A0B66-BC13-44E1-8CD3-E07AF9EB8212Q36487845-450FAFB7-6D00-413D-BD8D-60C106843658Q36553805-4BB6FE33-17A5-4F08-B5BA-E21F6DC21D76
P2860
Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Cell-based measures of viral p ...... PD-1)-expressing CD4+ T cells.
@en
type
label
Cell-based measures of viral p ...... PD-1)-expressing CD4+ T cells.
@en
prefLabel
Cell-based measures of viral p ...... PD-1)-expressing CD4+ T cells.
@en
P2093
P2860
P50
P356
P1476
Cell-based measures of viral p ...... PD-1)-expressing CD4+ T cells.
@en
P2093
Elizabeth Sinclair
Hiroyu Hatano
Jeffrey N Martin
Joseph M McCune
Peter W Hunt
Rebecca Hoh
Vivek Jain
P2860
P356
10.1093/INFDIS/JIS630
P407
P577
2012-10-22T00:00:00Z